Biodexa Pharmaceuticals files to sell 1.28B shares for holders

seekingalpha03-19

Biodexa Pharmaceuticals (NASDAQ:BDRX) Monday filed a prospectus related to the proposed resale of about 1.28B shares, representing about 3.21M ADS, by selling stockholders. This prospectus is not an ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2420238208?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-19 04:46","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2420238208","market":"nz","top_or_hot":-1,"title":"Biodexa Pharmaceuticals files to sell 1.28B shares for holders","media":"seekingalpha","content":"<div>\n<p>Biodexa Pharmaceuticals (NASDAQ:BDRX) Monday filed a prospectus related to the proposed resale of about 1.28B shares, representing about 3.21M ADS, by selling stockholders.\nThis prospectus is not an ...</p>\n\n<a href=\"https://seekingalpha.com/news/4080789-biodexa-pharmaceuticals-files-to-sell-128b-shares-for-holders\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biodexa Pharmaceuticals files to sell 1.28B shares for holders</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiodexa Pharmaceuticals files to sell 1.28B shares for holders\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-19 04:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4080789-biodexa-pharmaceuticals-files-to-sell-128b-shares-for-holders><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biodexa Pharmaceuticals (NASDAQ:BDRX) Monday filed a prospectus related to the proposed resale of about 1.28B shares, representing about 3.21M ADS, by selling stockholders.\nThis prospectus is not an ...</p>\n\n<a href=\"https://seekingalpha.com/news/4080789-biodexa-pharmaceuticals-files-to-sell-128b-shares-for-holders\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BDRX","symbol_name":"BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD","start_time":0,"source_url":"https://seekingalpha.com/news/4080789-biodexa-pharmaceuticals-files-to-sell-128b-shares-for-holders","article_id":"2420238208","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2420238208","pubTimestamp":1710794780,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Biodexa Pharmaceuticals  Monday filed a prospectus related to the proposed resale of about 1.28B shares, representing about 3.21M ADS, by selling stockholders.This prospectus is not an offer to sell these securities.More on Biodexa Pharmaceuticals  Biodexa stock slides 7% amid data for two drug studies Biodexa stock jumps on allowance of U.S. patent covering Tolimidone Seeking Alpha’s Quant Rating on Biodexa Pharmaceuticals Historical earnings data for Biodexa Pharmaceuticals Financial information for Biodexa Pharmaceuticals","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BDRX":"BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD","BK4139":"生物科技"},"translate_title":"Biodexa制药公司申请向股东出售128B股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BDRX":1},"content_text":"Biodexa Pharmaceuticals (NASDAQ:BDRX) Monday filed a prospectus related to the proposed resale of about 1.28B shares, representing about 3.21M ADS, by selling stockholders.\nThis prospectus is not an offer to sell these securities.\nSEC Filing\n\n\nMore on Biodexa Pharmaceuticals  Biodexa stock slides 7% amid data for two drug studies Biodexa stock jumps on allowance of U.S. patent covering Tolimidone Seeking Alpha’s Quant Rating on Biodexa Pharmaceuticals Historical earnings data for Biodexa Pharmaceuticals Financial information for Biodexa Pharmaceuticals","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2420238208"}